BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2011
View Archived Issues
Novel inhibitors of glycoprotein-mediated viral entry reported by Microbiotix
Read More
Novel adenosine A2A receptor antagonists patented
Read More
Ongoing phase I/II trial suggests safety of CDCA1-A24-56 vaccine in patients with CRPC
Read More
New vaccine targeting morphine dependency shows promise in rats
Read More
Merck & Co. patents novel glucocorticoid receptor modulators
Read More
Scientists at Vantia prepare new kallikrein-1 inhibitors
Read More
Italian scientists prepare novel histone deacetylase inhibitors for cancer
Read More
FDA approves Abbott's Xience nano stent for coronary artery disease in small vessels
Read More
Radius Health provides update on BA-058 formulations for osteoporosis
Read More
MGMTP140K gene-modified cells are safe and confer chemoprotection in phase I/II glioblastoma trial
Read More
New selective glucocorticoid receptor antagonists prevent olanzapine-induced weight gain in vivo
Read More
Monoclonal antibody against beta-amyloid reduces symptoms of AMD in vivo
Read More
NeuroSearch to conduct phase III confirmatory trial of Huntexil
Read More
Evotec and PsychoGenics form strategic alliance for CNS drug discovery solutions
Read More
EMD Serono launches Cyanokit in Canada for cyanide poisoning
Read More
ViroPharma begins phase II trial of VP-20621 for prevention of CDI recurrence
Read More
Johnson & Johnson designs new delta opioid receptor ligands
Read More
KemPharm reports results from phase I KP-201 trial
Read More
Metabolex begins phase II trial of arhalofenate in patients with gout
Read More
Daiichi Sankyo launches vaccine for prevention of measles and rubella in Japan
Read More
Orion patents new androgen receptor modulators for prostate cancer
Read More
Advantagene and FDA agree on SPA for phase III ProstAtak trial
Read More
Primary endpoints met in Vivus' phase III trial of avanafil for ED after radical prostatectomy
Read More
Proteostasis Therapeutics and Elan join to discover treatments for neurodegenerative disorders
Read More
Achillion's ACH-2684 advances to first-in-human study in chronic hepatitis C
Read More